Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/1996
08/21/1996EP0593440B1 Use of honey as vaccine
08/21/1996EP0589949B1 New peptides (didemnins), their preparation and their use
08/21/1996EP0589893B1 Use of a bacteriocin antimicrobial agent for the manufacture of a medicament for the treatment of gastric disorders associated with Helicobacter pylori.
08/21/1996EP0516691B1 Neuropeptide control of ocular growth
08/21/1996EP0500844B1 Drug containing cd14
08/21/1996EP0474787B1 A process for treating infertility and an agent for use in the process
08/21/1996EP0441886B1 Expression and processing of acetylated fgf's in yeast
08/21/1996CN1129460A Epstein-barr virus dna sequences encoding diagnostically relevant virus capid antigen, expression clones derived through polymerase chain reaction and the use of this recombinant antigen in diagnostic
08/21/1996CN1129224A Glucagon-like insulinotropic peptide analogs, compositions, and methods of use
08/21/1996CN1129140A Preparation method for biologic preparation using gamma-linolenic acid as main ingredient and application thereof
08/21/1996CN1129139A Use of azoles as virucidal agents in solutions of biologically active proteins
08/21/1996CN1129101A Compounded injection of ribonucleic acid and heparin
08/20/1996US5548068 Somatotropins with alterations in the alpha-helix 1 region, and combinations with other mutations
08/20/1996US5548064 Colony stimulating factor; oral administering
08/20/1996US5548062 Oligo(or poly)peptide
08/20/1996US5548061 Human endothelin-3 precursor protein
08/20/1996US5547964 Antiemetic during drug therapy
08/20/1996US5547940 Using a polypeptide
08/20/1996US5547939 Broad spectrum antimicrobial compounds and methods of use
08/20/1996US5547938 Administering glicentin to inhibit peristalsis in stomach or duodenum
08/20/1996US5547937 Treatment of respiratory distress syndrome
08/20/1996US5547936 Using an oligopeptide
08/20/1996US5547935 Muteins of human epidermal growth factor exhibiting enhanced binding at low PH
08/20/1996US5547934 A polypeptide which acts as a fungicide and a protozoicide
08/20/1996US5547933 Production of erythropoietin
08/20/1996US5547932 Transfection
08/20/1996US5547931 Administering to mammal prior to administering chemotherapy or dosage of irradiation by subcutaneous injection
08/20/1996US5547930 Sustained active release
08/20/1996US5547929 A parenteral composition comprising a soluble phase of a monomeric insulin analog and a solid phase of insulin-neutral protamine hagedorn crystals; provides a rapid onset and prolonged duration of action
08/20/1996US5547927 Soy protein hydrolyzate
08/20/1996US5547856 Hepatocyte growth factor variants
08/20/1996US5547853 CD2-binding domain of lymphocyte function associated antigen 3
08/20/1996US5547852 Composition containing the P40 subunit of interleukin-12
08/20/1996US5547696 Growth hormone stabilized with valine
08/20/1996US5547687 Method for removing phenylalanine from proteinaceous compositions, a product so obtained and use thereof
08/20/1996US5547674 Pharmaceutical preparations derived from European mistletoe
08/20/1996US5547669 Isolated peptide comprising regions having human t-cell stimulating activity, each comprising t-cell epitope of protein allergen arranged in configuration different from that occuring naturally
08/20/1996US5547666 Antibiotic GE 2270 factors A1, A2, A3 and H
08/20/1996US5547665 Method for removing nits from hair
08/20/1996US5547467 Method for measuring a blood component content of blood
08/20/1996CA2090719C In vivo delivery of active factors by co-cultured cell implants
08/18/1996CA2169810A1 Formulated medicines and processed foods to treat and prevent stomatitis
08/18/1996CA2168303A1 Azepinone compounds useful in the inhibition of ace and nep
08/15/1996WO1996024692A1 Lil-stat dna binding sites and methods for identifying inhibitory binding agents
08/15/1996WO1996024684A1 Potentiators of antibacterial agents
08/15/1996WO1996024676A1 Bioactive fusion proteins and pre-existing tumor therapy
08/15/1996WO1996024675A1 GnRH-LEUKOTOXIN CHIMERAS
08/15/1996WO1996024673A1 Mucosal vascular addressins and uses thereof
08/15/1996WO1996024672A1 NUCLEOTIDE AND DEDUCED AMINO ACID SEQUENCES OF TUMOR GENE Int6
08/15/1996WO1996024669A1 Human pancreatic cell lines: developments and uses
08/15/1996WO1996024668A1 Human chemokine beta-11 and human chemokine alpha-1
08/15/1996WO1996024650A2 Cytoplasmic antiproteinase-2 and cytoplasmic antiproteinase-3 and coding sequences
08/15/1996WO1996024618A1 Calcitonin salmon analogues, their preparation, medicinal use and use as analytical agents
08/15/1996WO1996024617A1 Desaminononapeptides, process for preparing the same and their use for preparing elcatonin
08/15/1996WO1996024616A1 PROCESS FOR PREPARING CALCITONIN AND L-α-AMINOSUBERIC ACID DERIVATIVES BY ENZYMATIC CONDENSATION
08/15/1996WO1996024614A1 Chromatographic purification of vancomycin hydrochloride by the use of preparative hplc
08/15/1996WO1996024613A1 A process for preparing certain aza cyclohexapeptides
08/15/1996WO1996024612A1 Novel farnesyl transferase inhibitors, preparation thereof, and pharmaceutical compositions containing same
08/15/1996WO1996024611A1 Novel farnesyl transferase inhibitors, preparation thereof, and pharmaceutical compositions containing same
08/15/1996WO1996024610A1 BRANCHED TRIPEPTIDE COMBINATORIAL LIBRARIES AND USE IN uPA MEDIATED DISORDERS
08/15/1996WO1996024609A1 Thrombin inhibitors
08/15/1996WO1996024608A1 Basic oxazoline-amide derivatives of ge 2270 and ge 2270-like antibiotics
08/15/1996WO1996024607A1 Basic proline-amide derivatives of ge 2270 and ge 2270-like antibiotics
08/15/1996WO1996024604A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease
08/15/1996WO1996024380A1 Methods and compositions for regulation of cd28 expression
08/15/1996WO1996024379A1 Cancer control
08/15/1996WO1996024378A2 Delivery of exogenous compounds
08/15/1996WO1996024377A1 Medicament in particle form
08/15/1996WO1996024373A2 Combination of angiotensin converting enzyme inhibitor and side-effect-reduced amount of aldosterone antagonist
08/15/1996WO1996024372A2 Combination of angiotensin converting enzyme inhibitor, side-effect-reduced amount of aldosterone antagonist and diuretic
08/15/1996WO1996024371A1 Multifunctional enzyme
08/15/1996WO1996024370A1 Pharmaceutical non inorganic saline solutions for endonasal administration of a calcitonin
08/15/1996WO1996024369A1 Formulations for il-12
08/15/1996WO1996024368A1 Method of using lectins for prevention and treatment of oral and alimentary tract disorders
08/15/1996WO1996024348A2 Use of carbazole compounds for the treatment of congestive heart failure
08/15/1996WO1996024345A2 Uses of a vitamin of the k-group against a loss of cognitive faculties
08/15/1996WO1996024343A1 Use of lck sh2 specific compounds to treat autoimmune diseases and allograft rejection
08/15/1996WO1996024342A1 Concomitant treatment with oral bismuth compounds
08/15/1996WO1996024341A1 Concomitant treatment with bismuth and antibacterials
08/15/1996WO1996024334A1 Lipid constructs for cytoplasmic delivery of agents
08/15/1996WO1996015240A3 Ribozyme analogs
08/15/1996WO1996013598A3 Hybrid adenovirus-aav virus and method of use thereof
08/15/1996WO1996013590A3 New sequences of hepatitis c virus genotypes and their use as prophylactic, therapeutic and diagnostic agents
08/15/1996WO1996012019A3 Her4 human receptor tyrosine kinase or the epidermal growth factor receptor family
08/15/1996WO1996007397A3 Delivery of solid drug compositions
08/15/1996CA2212731A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease
08/15/1996CA2212716A1 Lil-stat dna binding sites and methods for identifying inhibitory binding agents
08/15/1996CA2212713A1 Combination of angiotensin converting enzyme inhibitor and side-effect-reduced amount of aldosterone antagonist
08/15/1996CA2212712A1 Combination of angiotensin converting enzyme inhibitor, side-effect-reduced amount of aldosterone antagonist and diuretic
08/15/1996CA2212682A1 Delivery of exogenous compounds
08/15/1996CA2212645A1 Use of lck sh2 specific compounds to treat autoimmune diseases and allograft rejection
08/15/1996CA2212573A1 Nucleotide and deduced amino acid sequences of tumor gene int6
08/15/1996CA2212533A1 Multifunctional enzyme
08/15/1996CA2212520A1 Pharmaceutical non inorganic saline solutions for endonasal administration of a calcitonin
08/15/1996CA2212464A1 Potentiators of antibacterial agents
08/15/1996CA2212437A1 Basic oxazoline-amide derivatives of ge 2270 and ge 2270-like antibiotics
08/15/1996CA2212386A1 Cytoplasmic antiproteinase-2 and cytoplasmic antiproteinase-3 and coding sequences
08/15/1996CA2212372A1 Basic proline-amide derivatives of ge 2270 and ge 2270-like antibiotics
08/15/1996CA2212054A1 Gnrh-leukotoxin chimeras
08/15/1996CA2210989A1 Thrombin inhibitors
1 ... 2772 2773 2774 2775 2776 2777 2778 2779 2780 2781 2782 2783 2784 2785 2786 2787 2788 2789 2790 2791 2792 ... 3163